Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BioHarvest Sciences Inc. before investing.

In this article, we go over a few key elements for understanding BioHarvest Sciences Inc.’s stock price such as:

• BioHarvest Sciences Inc.’s current stock price and volume
• Why BioHarvest Sciences Inc.’s stock price changed recently
• Upgrades and downgrades for BHST from analysts
• BHST’s stock price momentum as measured by its relative strength

About BioHarvest Sciences Inc. (BHST)

Before we jump into BioHarvest Sciences Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Want to learn more about BioHarvest Sciences Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s Stock Price as of Market Close

As of November 25, 2025, 9:30 AM, CST, BioHarvest Sciences Inc.’s stock price was $6.750.

BioHarvest Sciences Inc. is down 0.44% from its previous closing price of $6.780.

During the last market session, BioHarvest Sciences Inc.’s stock traded between $6.750 and $6.750. Currently, there are approximately 17.42 million shares outstanding for BioHarvest Sciences Inc..

BioHarvest Sciences Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

BioHarvest Sciences Inc. Stock Price History

BioHarvest Sciences Inc.’s (BHST) price is currently down 24.58% so far this month.

During the month of November, BioHarvest Sciences Inc.’s stock price has reached a high of $9.280 and a low of $5.800.

Over the last year, BioHarvest Sciences Inc. has hit prices as high as $12.800 and as low as $4.724. Year to date, BioHarvest Sciences Inc.’s stock is up 9.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BioHarvest Sciences Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 24, 2025, there was 1 analyst who downgraded BioHarvest Sciences Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BioHarvest Sciences Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BioHarvest Sciences Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BioHarvest Sciences Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BioHarvest Sciences Inc. (BHST) by visiting AAII Stock Evaluator.

Relative Price Strength of BioHarvest Sciences Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 24, 2025, BioHarvest Sciences Inc. has a weighted four-quarter relative price strength of -3.75%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how BioHarvest Sciences Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BioHarvest Sciences Inc. Stock Price: Bottom Line

As of November 25, 2025, BioHarvest Sciences Inc.’s stock price is $6.750, which is down 0.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BioHarvest Sciences Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.